Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
CrowdStrike Holdings acquisition of Reposify
We are advising CrowdStrike on the transaction
Pon sale of interest in Hiller to Littlejohn & Co.
We advised Pon on the transaction
Alignment Healthcare $132.75 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Roivant Sciences $400 million at-the-market offering
We advised the company on an SEC-registered at-the-market offering
Home Depot $3 billion notes offering
The investment-grade notes are due 2025, 2032 and 2052
IDEAYA Biosciences $92 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
Interra Acquisition HK$1 billion IPO
We advised the SPAC on its IPO and HKEX listing
Niagara Mohawk Power $500 million green senior notes offering
The investment-grade notes are due 2052
Tailwind Capital sale of Stratix
We advised Tailwind Capital on the transaction
BBVA $1.75 billion senior non-preferred notes offering
We advised BBVA on its offering of senior non-preferred fixed-to-fixed-rate notes